Zobrazeno 1 - 10 of 16 pro vyhledávání: '"Keiichi Igarashi Hanaoka"'
1
Akademický článek
One-year clinical outcomes of patients with versus without acute coronary syndrome with 3-month duration of dual antiplatelet therapy after everolimus-eluting stent implantation.
Autor: Masahiro Natsuaki, Takeshi Morimoto, Erika Yamamoto, Hirotoshi Watanabe, Yutaka Furukawa, Mitsuru Abe, Koichi Nakao, Tetsuya Ishikawa, Kazuya Kawai, Kei Yunoki, Shogo Shimizu, Masaharu Akao, Shinji Miki, Masashi Yamamoto, Hisayuki Okada, Kozo Hoshino, Kazushige Kadota, Yoshihiro Morino, Keiichi Igarashi Hanaoka, Kengo Tanabe, Ken Kozuma, Takeshi Kimura, STOPDAPT trial investigators
Publikováno v: PLoS ONE, Vol 15, Iss 3, p e0227612 (2020)
There has been no previous prospective study evaluating 3-month dual antiplatelet therapy (DAPT) after cobalt-chromium everolimus-eluting stent (CoCr-EES) implantation in patients with acute coronary syndrome (ACS). The STOPDAPT trial is a prospectiv
Externí odkaz: https://doaj.org/article/aabfa867a4f3422a9b48c12eb7f0132f
Zobrazit plný text záznamu
2
Akademický článek
Ischemic and Bleeding Risk After Percutaneous Coronary Intervention in Patients With Prior Ischemic and Hemorrhagic Stroke
Autor: Masahiro Natsuaki, Takeshi Morimoto, Hirotoshi Watanabe, Yoshihisa Nakagawa, Yutaka Furukawa, Kazushige Kadota, Takashi Akasaka, Keiichi Igarashi Hanaoka, Ken Kozuma, Kengo Tanabe, Yoshihiro Morino, Toshiya Muramatsu, Takeshi Kimura
Publikováno v: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 8, Iss 22 (2019)
Background Prior stroke is regarded as risk factor for bleeding after percutaneous coronary intervention (PCI). However, there is a paucity of data on detailed bleeding risk of patients with prior hemorrhagic and ischemic strokes after PCI. Methods a
Externí odkaz: https://doaj.org/article/0360ca9acb35418db884bf8efaff32f4
Zobrazit plný text záznamu
3
Akademický článek
Prediction of Thrombotic and Bleeding Events After Percutaneous Coronary Intervention: CREDO‐Kyoto Thrombotic and Bleeding Risk Scores
Autor: Masahiro Natsuaki, Takeshi Morimoto, Kyohei Yamaji, Hirotoshi Watanabe, Yusuke Yoshikawa, Hiroki Shiomi, Yoshihisa Nakagawa, Yutaka Furukawa, Kazushige Kadota, Kenji Ando, Takashi Akasaka, Keiichi Igarashi Hanaoka, Ken Kozuma, Kengo Tanabe, Yoshihiro Morino, Toshiya Muramatsu, Takeshi Kimura
Publikováno v: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 7, Iss 11 (2018)
BackgroundPrediction of thrombotic and bleeding risk is important to optimize antithrombotic therapy after percutaneous coronary intervention. Methods and ResultsWe developed the prediction rules for thrombotic and bleeding events separately in Japan
Externí odkaz: https://doaj.org/article/f227a7c5aa594db3bf1380b7921fc2ca
Zobrazit plný text záznamu
4
Randomized Comparison Between Everolimus-Eluting Bioresorbable Scaffold and Metallic Stent
Autor: Yasuhiro Honda, Atsuo Namiki, Satoshi Yasuda, Jeffrey J. Popma, Richard Rapoza, Keiichi Igarashi Hanaoka, Charles A. Simonton, Gregg W. Stone, Hajime Kusano, Taku Asano, Kozo Okada, Kenji Ando, Jungo Furuya, Kengo Tanabe, Ken Kozuma, Takeshi Kimura, Hideki Kitahara, Yukio Ozaki, Hiroki Shiomi, Yoshinobu Onuma, Peter J. Fitzgerald, Takafumi Ueno, Masafumi Ono, Patrick W. Serruys
Publikováno v: JACC: Cardiovascular Interventions. 13:116-127
Objectives: The aim of this study was to investigate the vascular responses and fates of the scaffold after bioresorbable vascular scaffold (BVS) implantation using multimodality imaging. Background: Serial comprehensive image assessments after BVS i
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::690c03f198e9e86a733d148d06d2576f
https://doi.org/10.1016/j.jcin.2019.09.047
Zobrazit plný text záznamu
8
Clopidogrel Monotherapy vs. Aspirin Monotherapy Following Short-Term Dual Antiplatelet Therapy in Patients Receiving Everolimus-Eluting Coronary Stent Implantation
Autor: Yuji Ikari, Kenji Ando, Yoshihiro Morino, Kazuya Kawai, Kazushige Kadota, Keiichi Igarashi Hanaoka, Kengo Tanabe, Takeshi Morimoto, Mitsuru Abe, Stopdapt Investigators, Takeshi Kimura, Hirotoshi Watanabe, Koichi Nakao, Masahiro Natsuaki, Ken Kozuma
Publikováno v: Circulation journal : official journal of the Japanese Circulation Society. 84(9)
Background There is a scarcity of data on short-duration dual antiplatelet therapy (DAPT) followed by P2Y12 inhibitor monotherapy as compared with aspirin monotherapy after percutaneous coronary intervention (PCI).Methods and Results:STOPDAPT-1 is a
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9903d356f82753fac3b3dc0e0a2199c
https://pubmed.ncbi.nlm.nih.gov/32713888
Zobrazit plný text záznamu
9
Randomized Comparison Between Everolimus-Eluting Bioresorbable Scaffold and Metallic Stent Multimodality Imaging Through 3 Years
Autor: Yoshinobu, Onuma, Yasuhiro, Honda, Taku, Asano, Hiroki, Shiomi, Ken, Kozuma, Yukio, Ozaki, Atsuo, Namiki, Satoshi, Yasuda, Takafumi, Ueno, Kenji, Ando, Jungo, Furuya, Keiichi Igarashi, Hanaoka, Kengo, Tanabe, Kozo, Okada, Hideki, Kitahara, Masafumi, Ono, Hajime, Kusano, Richard, Rapoza, Charles, Simonton, Jeffrey J, Popma, Gregg W, Stone, Peter J, Fitzgerald, Patrick W, Serruys, Takeshi, Kimura
Publikováno v: JACC-Cardiovascular interventions, 13(1), 116-127. Elsevier Inc.
JACC. Cardiovascular interventions, 13(1), 116-127. Elsevier Inc.
Objectives: The aim of this study was to investigate the vascular responses and fates of the scaffold after bioresorbable vascular scaffold (BVS) implantation using multimodality imaging. Background: Serial comprehensive image assessments after BVS i
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::4dc1c906e05c109b021fc1d8f22d6295
https://pure.eur.nl/en/publications/40dfb43e-5e46-4024-987e-005cbc8564a0
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje